reboxetine has been researched along with methylphenidate in 10 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (methylphenidate) | Trials (methylphenidate) | Recent Studies (post-2010) (methylphenidate) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 7,783 | 1,698 | 2,693 |
| Protein | Taxonomy | reboxetine (IC50) | methylphenidate (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.061 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.083 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 5.1 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.079 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bymaster, FP; Davis, RJ; McKinzie, DL; Nomikos, GG; Overshiner, CD; Perry, KW; Tzavara, ET; Witkin, JM; Wolff, M | 1 |
| Cak, HT; Cetin, FC | 1 |
| Arabgol, F; Hebrani, P; Panaghi, L | 1 |
| Carson, RE; Ding, YS; Gallezot, JD; Hannestad, J; Lin, SF; Malison, RT; Planeta-Wilson, B; van Dyck, CH; Williams, WA | 1 |
| Alamo, C; García-Campos, N; López-Muñoz, F; Loro, M; Quintero, J | 1 |
| Robinson, ES | 1 |
| Duchateau, J; Fontenelle, V; Klass, M; Lévénez, M; Meeusen, R; Pattyn, N; Roelands, B | 1 |
| Chiu, GS; Freund, GG; Gainey, SJ; Kaczmarczyk, MM; Kelley, KW; Kwakwa, KA; Lawson, MA; Machaj, AS; Martin, SA; Meling, DD; Miller, MJ; Newman, AF; Wang, Y; Woods, JA; York, JM | 1 |
| Connell, CJW; Gant, N; Srzich, A; Thompson, B; Turuwhenua, J | 1 |
| Chung, HK; Grueschow, M; Hayward-Könnecke, H; Jetter, A; Quednow, BB; Sidorenko, N; Tobler, PN | 1 |
6 trial(s) available for reboxetine and methylphenidate
| Article | Year |
|---|---|
Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Double-Blind Method; Female; Humans; Male; Methylphenidate; Morpholines; Reboxetine | 2009 |
Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo.
Topics: Adult; Brain; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female; Humans; Magnetic Resonance Imaging; Male; Methylphenidate; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Positron-Emission Tomography; Radioligand Assay; Reboxetine | 2010 |
Reboxetine for ADHD in children non-responders or with poor tolerance to methylphenidate: a prospective long-term open-label study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Drug Resistance; Female; Humans; Male; Methylphenidate; Morpholines; Prospective Studies; Reboxetine; Severity of Illness Index | 2010 |
Effects of noradrenaline and dopamine on supraspinal fatigue in well-trained men.
Topics: Adrenergic alpha-Agonists; Adult; Athletic Performance; Bicycling; Dopamine; Dopamine Uptake Inhibitors; Humans; Male; Methylphenidate; Morpholines; Motor Cortex; Muscle Contraction; Muscle Fatigue; Neurofeedback; Norepinephrine; Physical Fitness; Pyramidal Tracts; Reboxetine; Transcranial Magnetic Stimulation; Young Adult | 2012 |
Effects of Dopamine and Norepinephrine on Exercise-induced Oculomotor Fatigue.
Topics: Adrenergic Uptake Inhibitors; Adult; Cross-Over Studies; Dopamine; Dopamine Uptake Inhibitors; Exercise; Eye Movements; Fatigue; Female; Humans; Male; Methylphenidate; Middle Aged; Morpholines; Norepinephrine; Reboxetine; Synaptic Transmission; Young Adult | 2017 |
Acetylcholine and noradrenaline enhance foraging optimality in humans.
Topics: Acetylcholine; Double-Blind Method; Humans; Methylphenidate; Nicotine; Norepinephrine; Reboxetine | 2023 |
4 other study(ies) available for reboxetine and methylphenidate
| Article | Year |
|---|---|
Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine.
Topics: Acetylcholine; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Cerebral Cortex; Cholinergic Fibers; Hippocampus; Male; Maze Learning; Methylphenidate; Microdialysis; Morpholines; Norepinephrine; Pattern Recognition, Visual; Propylamines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reboxetine; Receptors, Dopamine | 2006 |
Reboxetine use in the treatment of attention-deficit/hyperactivity disorder.
Topics: Adolescent; Antidepressive Agents; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Imipramine; Male; Methylphenidate; Morpholines; Reboxetine | 2006 |
Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks.
Topics: Adrenergic Uptake Inhibitors; Animals; Animals, Outbred Strains; Atomoxetine Hydrochloride; Attention; Choice Behavior; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Methylphenidate; Morpholines; Propylamines; Rats; Reaction Time; Reboxetine; Serial Learning; Time Factors | 2012 |
Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Anxiety; Blood Glucose; Body Weight; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Cerebral Cortex; Cytokines; Desipramine; Dietary Fats; Dopamine; Exploratory Behavior; Gene Expression Regulation; Hippocampus; Homovanillic Acid; Indoleamine-Pyrrole 2,3,-Dioxygenase; Learning Disabilities; Male; Maze Learning; Memory Disorders; Methylphenidate; Mice; Mice, Knockout; Monoamine Oxidase; Morpholines; Motor Activity; Overnutrition; Physical Endurance; Reboxetine; Receptors, Interleukin-1 Type I; Recognition, Psychology | 2013 |